期刊文献+

基因修饰对消化道肿瘤细胞化疗药敏感性的影响

Retrovirus-mediated Transduction of Uracil Phosphoribosyltransferase Gene Render Alimentary Tumor Cells More Sensitive to 5-Fluorouracil in Vitro
下载PDF
导出
摘要 目的:探讨UPRT基因修饰消化道肿瘤细胞后对5-氟脲嘧啶(5-FU)杀伤效应的增强作用。方法:采用PCR技术从大肠杆菌K12菌株基因组中扩增UPRT基因,并构建pLXSN逆转录病毒表达载体,进一步转染人胃癌细胞株SCG7901、大肠癌细胞株Lovo以及肝癌细胞株7721。采用MTT法检测转导UPRT基因前后,肿瘤细胞对5-FU敏感性的变化。结果:通过逆转录病毒载体介导UPRT基因修饰肿瘤细胞,体外MTT法检测结果显示,转导UPRT基因后可使SCG7901、Lovo及7721对5-FU的敏感性分别提高约21.07、30.25及35.19倍。结论:UPRT基因修饰肿瘤细胞,能明显提高其对5-FU杀伤的敏感性,增强5-FU的抗瘤效应。 Objective:To investigate the killing effects of UPRT/5-FU Enzyme /Prodrug System to alimentary tumor cells.Methods:The UPRT gene encoding uracil phosphoribosyltrans-ferase was amplified from E.Coli K12genome and subcloned into retrovirus expression vec tor pLXSN,Recombinant retrovirus was used further to infect human gastric cancer cell line SCG7901、colon cancer cell line Lovo and hepatic cancer cell line7721.The sensitivity of tumor cells transduced with UPRT gene to5-FU in vitro was detected by MTT method.Results:Trans-duction of UPRT gene into SCG7901、Lovo and7721cell lines can render them more sensitive to5-FU,which increased with21.07-fold、30.25-fold and35.19-fold independently.Conclusion:Transduction of UPRT gene can render the tumor cell lines be more sensitive to low concentra-tion of5-FU and improve significantly the antitumor effect of5-FU in vitro.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第12期837-840,共4页 Chinese Journal of Clinical Oncology
基金 上海市自然科学基金资助(编号:98ZB14028)
关键词 消化道肿瘤 5-氟脲嘧啶 脲嘧啶磷酸核糖转移酶 Alimentary tumor5-Fluorouracil Uracil phosphoribosyltransferase
  • 相关文献

参考文献12

  • 1[1]Farzin F, Uwe T, Wolffram S, et al. Gene therapy of cancer [J]. Immunol Today, 1998,19(7): 294~296
  • 2[2]Widjojoatmodjo MN, Fluit AC, Verhoef J. Rapid identification of bacteria by PGR-Single-Strand conformation polymorphism [J]. J Clin Microbiol, 1994, 32(12): 3002~3007
  • 3[3]Fumihiko K, Takayuki K, Hirofumi H, et al. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitize cancer cells to low concentration of 5-fluorouracil [J]. Cancer Res, 1998, 58(9): 1946~1951
  • 4[4]Takechi T, Koizumi K, Tsujimoto H, et al. Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells [J]. Jpn J Cancer Res, 2001, 92(6):696~ 703
  • 5[5]Habara K, Ajiki T, Kamigaki T, et al. High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro [J]. Jpn J Cancer Res, 2001,92(10): 1127~1132
  • 6[6]Inaba M, Sawada H, Sadata A, et al. Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction [J]. Jpn J Cancer Res, 1999, 90(3): 349~354
  • 7[7]Tanaka-Nozaki M, Onda M, Tanaka N, et al. Variations in 5-fiuorouracil concentrations of colorectal tissues as compared with dihydropyrimidine dehydrogenase (DPD) enzyme activities and DPD messenger RNA levels [J]. Clin Cancer Res, 2001,7(9): 2783~2787
  • 8[8]Koyama F, Sawada H, Hirao T, et al. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine [J]. Cancer Gene Ther, 2000, 7(7): 1015~1022
  • 9[9]Uckert W, Kammertons T, Haack K, et al. Double suicide gene (cytosine deaminase and Herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo [J]. Hum Gene Ther, 1998, 9(6): 855~865
  • 10[10]McPake CR, Shetty S, Kitchingman GR, et al. Wild-type p53induction mediated by replication-deficient adenoviral vectors [J]. Cancer Res, 1999, 59(17): 4247~4251

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部